Search

Your search keyword '"Bernhardt, Wanja"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Bernhardt, Wanja" Remove constraint Author: "Bernhardt, Wanja"
49 results on '"Bernhardt, Wanja"'

Search Results

1. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

2. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

3. Diverse molecular causes of unsolved autosomal dominant tubulointerstitial kidney diseases

4. Refining genotype–phenotype correlations in 304 patients with autosomal recessive polycystic kidney disease and PKHD1 gene variants

5. Risk Factors for Early Dialysis Dependency in Autosomal Recessive Polycystic Kidney Disease

6. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

9. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

13. Early childhood height-adjusted total kidney volume as a risk marker of kidney survival in ARPKD

15. Similar humoral immune responses in peritoneal dialysis and haemodialysis patients after two doses of the SARS-CoV-2 vaccine BNT162b2

19. Refining genotype–phenotype correlations in 304 patients with autosomal recessive polycystic kidney disease and PKHD1 gene variants

20. Severe neurological outcomes after very early bilateral nephrectomies in patients with autosomal recessive polycystic kidney disease (ARPKD)

21. Early childhood height-adjusted total kidney volume as a risk marker of kidney survival in ARPKD

22. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition

38. Real-world study: Escalating targeted lipid-lowering treatment with PCSK9-inhibitors and lipoprotein apheresis

39. Risk Factors for Early Dialysis Dependency in Autosomal Recessive Polycystic Kidney Disease

41. Prolyl-hydroxylase inhibitor activating hypoxia-inducible transcription factors reduce levels of transplant arteriosclerosis in a murine aortic allograft model

42. Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens

43. Activation of Hypoxia Inducible Factor 1 Is a General Phenomenon in Infections with Human Pathogens

48. HIF Activation Protects From Acute Kidney Injury

49. Stabilization of hypoxia inducible factor rather than modulation of collagen metabolism improves cardiac function after acute myocardial infarction in rats

Catalog

Books, media, physical & digital resources